Gene: ZXDB
Official Full Name: zinc finger X-linked duplicated Bprovided by HGNC
Gene Summary: The ZXDB gene is one of a pair of duplicated zinc finger genes on chromosome Xp11.21 (Greig et al., 1993 [PubMed 8268913]); see also ZXDA (MIM 300235).[supplied by OMIM, Jul 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11842 | ZXDB Knockout cell line (HeLa) | Human | ZXDB | 1:3~1:6 | Negative | Online Inquiry |
KO11843 | ZXDB Knockout cell line (HCT 116) | Human | ZXDB | 1:2~1:4 | Negative | Online Inquiry |
KO11844 | ZXDB Knockout cell line (HEK293) | Human | ZXDB | 1:3~1:6 | Negative | Online Inquiry |
KO11845 | ZXDB Knockout cell line (A549) | Human | ZXDB | 1:3~1:4 | Negative | Online Inquiry |
ZXDB Gene Knockout Cell Lines are expertly engineered cellular models designed to facilitate the study of gene function and regulation. These cell lines are produced using advanced CRISPR-Cas9 technology, which allows for precise targeted gene disruption. By employing this method, ZXDB cell lines offer researchers a powerful tool to investigate the phenotypic consequences of gene knockouts, providing invaluable insights into gene function, pathways, and interactions.
The key mechanism of ZXDB Gene Knockout Cell Lines revolves around the targeted introduction of double-strand breaks in specific genomic regions, followed by the cellular repair processes that often result in gene inactivation. This leads to the generation of stable cell lines that can be used to study gene importance in various biological contexts, including cancer biology, developmental biology, and drug response analysis.
Scientifically, these cell lines serve as critical resources in both basic and translational research, enabling scientists to dissect complex biological questions that underlie human health and disease. Their applications are extensive, ranging from validating drug targets to elucidating the mechanisms of genetic disorders. By providing a systematic approach to gene knockout studies, ZXDB cell lines empower researchers to enhance their understanding and therapeutic strategies.
A distinct advantage of ZXDB Gene Knockout Cell Lines lies in their high specificity and efficiency, coupled with the reliability of CRISPR-based engineering, which reduces off-target effects compared to older gene editing methods. Furthermore, these cell lines are readily available across various cell types, ensuring compatibility with diverse research needs.
For researchers and clinicians, the value of ZXDB Gene Knockout Cell Lines is evident; they not only streamline the process of gene function studies but also significantly improve experimental reproducibility. This results in robust data that can accelerate discovery and innovation in the biomedical field.
Our company prides itself on cutting-edge gene editing technologies and a commitment to providing high-quality biological products, making us a trusted partner in advancing genetic research and therapeutic development. With ZXDB Gene Knockout Cell Lines, researchers can confidently explore the complexities of gene function in a way that is both efficient and impactful.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.